Aron Goldhirsch

机构：Harvard University, Feed Control (Norway), Istituti di Ricovero e Cura a Carattere Scientifico, International Breast Cancer Study Group, European Institute of Oncology

发表论文 753 篇 · 总被引 72814 次 · h-index 122

代表论文

• Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer (2023 · New England Journal of Medicine · 被引 225)
• Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer (2023 · JAMA Oncology · 被引 37)
• Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy (2024 · Journal of Clinical Oncology · 被引 29)
• Breastfeeding After Hormone Receptor–Positive Breast Cancer: Results From the POSITIVE Trial (2025 · Journal of Clinical Oncology · 被引 6)
• Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer (2024 · The Breast · 被引 6)
• LBA12 5-year follow-up results from the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial (2025 · Annals of Oncology · 被引 5)